Voxelotor in adolescents and adults with sickle cell disease (HOPE): long-term follow-up results of an international, randomised, double-blind, placebo-controlled, phase 3 trial.
暂无分享,去创建一个
K. Ataga | E. Vichinsky | I. Agodoa | A. El‐Beshlawy | J. Howard | J. Lehrer-Graiwer | M. Tonda | M. Achebe | V. Nduba | R. C. Brown | H. Hassab | S. Gray | R. C. Brown | R. Brown